BCAT2 and glioblastoma: IDH wild-type patient-derived (A11, S2, SP20, and A25) and established human (U87 and U251) and rat (C6) glioblastoma cell lines showed variable concentrations of BCAT1 and BCAT2 (Figure 1B–G; Supplementary Figure S1 A–D).